CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,000 shares at $2.00 ($2,000)
- 4/A Open-market buy Director bought 5,000 shares at $1.96 ($9,806)
- 4 Open-market buy Director bought 5,000 shares at $1.96 ($9,806)
- 4 Open-market buy Director bought 5,000 shares at $2.02 ($10,100)
- 4 Grant or award President and CEO acquired 8,251 shares (grant or award)
- 4 Open-market sale 10% owner sold 10,000 shares at $2.10 ($21,000)
- 4 Grant or award President and CEO acquired 8,052 shares (grant or award)
- 4 Grant or award President and CEO acquired 7,407 shares (grant or award)
- 4/A Open-market buy Director bought 5,000 shares at $2.28 ($11,400)
- 4 Open-market buy Director bought 5,000 shares at $2.28 ($11,400)
- 4 Open-market buy Director bought 5,000 shares at $2.34 ($11,700)
- 4 Open-market sale 10% owner sold 10,000 shares at $2.37 ($23,700)
- 4 Grant or award President and CEO acquired 6,337 shares (grant or award)
- 4 Grant or award President and CEO acquired 5,828 shares (grant or award)
- 4 Open-market sale 10% owner sold 10,000 shares at $3.19 ($31,900)
- 4 Open-market buy Director bought 2,000 shares at $3.17 ($6,340)
- 4 Grant or award President and CEO acquired 5,258 shares (grant or award)
Page 11 of 39 · 776 filings